Fifth Third Bancorp Harmony Biosciences Holdings, Inc. Transaction History
Fifth Third Bancorp
- $28.3 Billion
- Q2 2025
A detailed history of Fifth Third Bancorp transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 300 shares of HRMY stock, worth $7,977. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 319
5.96%
Holding current value
$7,977
Previous $10,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding HRMY
# of Institutions
290Shares Held
46.3MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$176 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$155 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$136 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$43.3 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$42.1 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.57B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...